Literature DB >> 12368574

Endothelins and markers of renal damage in recently diagnosed hypertensive patients.

Antonia Maldonado-Martín1, Dolores Rueda-Illescas, Blas Gil-Extremera, Leticia Soriano-Carrascosa, Trinidad Alonso-Morales, Francisco García-Pérez, José García-Chicano, Juan de Dios Luna del Castillo.   

Abstract

Endothelin has been identified as a potent vasoconstrictor. The aim of this study was to evaluate urinary endothelins and their relation to other markers of renal damage, such as microalbuminuria, creatinine, and N-acetyl-beta-glucosaminidase (NAG), in a group of recently diagnosed (less than 1 year) hypertensive subjects and a control group. We selected 50 subjects and divided them into two groups: 27 hypertensive patients (15 females and 12 males) without previous pharmacologic therapy, and 23 healthy, normotensive subjects (12 females and 11 males). All patients underwent a history and physical examination, chest x-ray, electrocardiography, funduscopy, and hematologic and biochemical analyses. Endothelins, microalbuminuria, creatinine, and NAG values were also determined in 24-hour urine samples. Creatinine, microalbuminuria, and NAG values were found to be higher in hypertensive than in normotensive subjects. The hypertensive group showed a nonsignificant elevation of total endothelin. In conclusion, the determination of elevated urinary endothelin does not appear to be an early marker of organ damage in hypertensive subjects. The urinary excretion of protein, creatinine, and NAG was higher in hypertensive subjects. A positive correlation was found between the urinary excretion of endothelins and markers of renal damage, microalbuminuria and NAG values. The relationship between endothelins and hypertension was without statistical significance. Copyright 2002 Le Jacq Communications, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12368574      PMCID: PMC8101869          DOI: 10.1111/j.1524-6175.2002.00489.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  27 in total

Review 1.  Microalbuminuria: a risk factor for vascular and renal complications of hypertension.

Authors:  N M Kaplan
Journal:  Am J Med       Date:  1992-04-27       Impact factor: 4.965

2.  The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study.

Authors:  J W Rowe; R Andres; J D Tobin; A H Norris; N W Shock
Journal:  J Gerontol       Date:  1976-03

3.  A novel potent vasoconstrictor peptide produced by vascular endothelial cells.

Authors:  M Yanagisawa; H Kurihara; S Kimura; Y Tomobe; M Kobayashi; Y Mitsui; Y Yazaki; K Goto; T Masaki
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

Review 4.  Endothelin peptides and compensatory growth of renal cells.

Authors:  M S Simonson
Journal:  Curr Opin Nephrol Hypertens       Date:  1994-01       Impact factor: 2.894

Review 5.  High-density lipoprotein cholesterol levels as a marker of reverse cholesterol transport.

Authors:  J T Gwynne
Journal:  Am J Cardiol       Date:  1989-10-03       Impact factor: 2.778

6.  The determinants and prognostic significance of serum uric acid in elderly patients of the European Working Party on High Blood Pressure in the Elderly trial.

Authors:  J Staessen
Journal:  Am J Med       Date:  1991-03       Impact factor: 4.965

Review 7.  Role of endothelin in mechanisms of local blood pressure control.

Authors:  T Masaki; M Yanagisawa; K Goto; S Kimura
Journal:  J Hypertens Suppl       Date:  1990-12

Review 8.  Renal function in hypertension.

Authors:  A Mimran
Journal:  Am J Med       Date:  1988-01-29       Impact factor: 4.965

Review 9.  Angiotensin and the renal circulation in hypertension.

Authors:  N K Hollenberg; G H Williams
Journal:  Circulation       Date:  1988-06       Impact factor: 29.690

10.  Elevated endothelin-1 plasma concentration in patients with essential hypertension.

Authors:  A Januszewicz; M Lapiński; B Symonides; E Dabrowska; A Kuch-Wocial; E Trzepla; H Ignatowska-Switalska; B Wocial; J Chodakowska; W Januszewicz
Journal:  J Cardiovasc Risk       Date:  1994-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.